Participant response to an internally designed patient questionnaire. This will measure several domains of of intervention acceptability: satisfaction with treatment, self-efficacy, burden of treatment, and intention to adhere. 6 questions will assess satisfaction with treatment, 3 questions will assess self-efficacy,1 question will assess burden of treatment and 1 question will assess intention to adhere. Each question will use a 5 point likert scale (0-4) with lower scores indicating higher satisfaction, self-efficacy, and intention to adhere. Each question will be reported individually.
How satisfied are you with the effect of your physiotherapy treatment?
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
0
0 – 0
How satisfied are you with your involvement in decision making about your physiotherapy treatment?
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
0
0 – 0
How satisfied were you with up to six physiotherapy sessions over three months after your injury?
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
0
0 – 0
How satisfied were you with the written information you were given describing the study?
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
0
0 – 0
How satisfied were you with the written information you were given about your injury?
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
0
0 – 1
How satisfied are you overall with the physiotherapy care you received after your injury?
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
0
0 – 0
How confident are you that you can return to all your normal activities?
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
0
0 – 1
How did doing your exercises fit into your weekly routine?
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
1
0 – 2
AdherencePrimary· 12 weeks
Percentage (0-100%) of scheduled physiotherapy sessions attended
Group
Value
95% CI
Individualized Exercise
56
Adherence [Participant-reported Adherence to Home Exercise Using a Likert Scale]Primary· 12 weeks
Participant response at follow-up to the question 'how often did you perform your exercises at least three times a week?' using a five-point Likert scale (0-4) anchored at 'always' (0) and 'never' (4)
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
4
Participants Who Completed and Returned Follow-up Outcome Data
5
Participants Who Completed and Returned Follow-up Outcome Data
2
Acceptability of Outcome Data CollectionSecondary· 12 weeks
Percentage (0-100%) of questions completed in the following patient-reported outcome measures: Lysholm Knee Scoring Scale, Tegner Activity Scale, EQ-5D-5L, completed at baseline and returned at 3-month follow-up
Baseline Lysholm Knee Scoring Scale
Group
Value
95% CI
Individualized Exercise
100
Baseline Tegner Activity Scale
Group
Value
95% CI
Individualized Exercise
100
Baseline EQ-5D-5L
Group
Value
95% CI
Individualized Exercise
100
Follow-up Lysholm Knee Scoring Scale
Group
Value
95% CI
Individualized Exercise
100
Follow-up Tegner Activity Scale
Group
Value
95% CI
Individualized Exercise
100
Follow-up EQ-5D-5L
Group
Value
95% CI
Individualized Exercise
100
Number of Treatment Related Adverse Events Experienced by ParticipantsSecondary· Through 12 weeks after first physiotherapy session
The total number and type of treatment related adverse events experienced by participants will be recorded. This will be recorded from commencement of the intervention to 12 week follow-up. Treatment related adverse events will be recorded by physiotherapists at each physiotherapy session and by participant self report at 12 week follow up.
Group
Value
95% CI
Individualized Exercise
1
Individualized Exercise
1
Individualized Exercise
13
Presence/Absence of Common Lateral Patella Dislocation Diagnostic CriteriaSecondary· Baseline
Following diagnosis of a lateral patellar dislocation by an orthopaedic surgeon or physiotherapist, the clinician will be asked which of the following proposed assessment findings to include in the eligibility criteria for future studies, were present/absent during their clinical examination: positive patella apprehension test, visible knee joint effusion or haemarthrosis, medial patellofemoral ligament tenderness on palpation, and a convincing patient history of a visible deformity on the lateral aspect of the knee or a sensation of the patella 'popping' out of joint followed by spontaneous r
Medial patellofemoral ligament tenderness
Group
Value
95% CI
Patients With a Diagnosed Lateral Patellar Dislocation
100
convincing history of a lateral patellar dislocation
Group
Value
95% CI
Patients With a Diagnosed Lateral Patellar Dislocation
93.3
visible knee joint effusion or haemarthrosis
Group
Value
95% CI
Patients With a Diagnosed Lateral Patellar Dislocation
66.7
positive patella apprehension test,
Group
Value
95% CI
Patients With a Diagnosed Lateral Patellar Dislocation
This measures activity on a scale from 0-10, with higher scores indicating higher activity. It will be administered as a patient completed questionnaire.
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
It is scored from 0-100 with lower scores indicating higher pain and disability. It will be administered as a patient completed questionnaire.
Group
Value
95% CI
Patients Who Returned Lysholm Knee Scoring Scale Outcome Data
90
76.5 – 95
Quality of Life Using the EQ-5D-5L QuestionnaireSecondary· 12 weeks
This assess quality of life using 5 domains: mobility, self-care, usual activities, pain/discomfort and anxiety/depress, each containing 5 options. These domains are combined to give a single score ranging from -0.594 to 1 for UK populations, with higher scores indicating higher quality of life. Participants rate their overall health on a visual analogue scale from 0 (worst health you can imagine) to 100 (the best help you can imagine). It will be administered as a patient completed questionnaire.
Index score
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
0.84
0.8 – 1
Health on a Visual Analogue Scale
Group
Value
95% CI
Participants Who Completed and Returned Follow-up Outcome Data
90
85 – 95
Adverse events — posted to ClinicalTrials.gov
Time frame: through 3 months after the first physiotherapy session.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Individualized Exercise
Serious: 0/15 (0%)
Deaths: 0/15
Other adverse events (2 terms — click to expand)
Reaction
System
Individualized Exercise
Knee pain or swelling after completing prescribed exercise that last >1 week
This study is a feasibility study. It will assess areas of uncertainty relating to the implementation of an individualised exercise programme for patients with a recent kneecap dislocation. This will help determine if a future larger study is feasible, and inform the design and conduct of future research that would aim to optimise outcomes after a kneecap dislocation.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by City, University of London
Last refreshed: 1 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03798483.